SEL212

Latest Posts

STOCKHOLM, July 2, 2024 /PRNewswire/ -- Sobi ® right this moment introduced the initiation...

Market

Sobi initiates rolling biologics license utility to FDA for SEL-212 for the potential remedy of power refractory gout By Investing.com